MedPath

on-invasive imaging of perfusion and oxygenation of the LOWer extremities in healthy volunteers by means of Multispectral Optoacoustic Tomography (LOW-MSOT)

Completed
Conditions
perfusion and oxygenation of the lower legs
10028302
10047043
10003216
Registration Number
NL-OMON38860
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

- Healthy volunteers.
- No prior or current medication.
- Age >= 18 years.
- Written informed consent.
- Adequate potential for telephone follow-up 14 days following the measurement with MSOT.

Exclusion Criteria

- Medical or psychiatric conditions that compromise the volunteers' ability to give informed consent.
- Concurrent uncontrolled medical conditions.
- Any investigational treatment for peripheral vascular disease or lower leg fractures within the past month.
- Pregnancy or breast feeding.
- Clinically significant (i.e. active) cardiovascular disease (e.g. congestive heart failure, symptomatic coronary artery disease and cardiac dysrhythmia, e.g. atrial fibrillation, even if controlled with medication, peripheral vascular disease) or myocardial infarction within the past 12 months.
- Patients with symptoms or history of peripheral neuropathy.
- (Partial) amputation of one of the legs.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Determination of the measurement variation (mean and SD) of MSOT in<br /><br>physiological conditions of the lower leg. correlation of MSOT oxygenation and<br /><br>perfusion measurements with pulse oximetry of the hallux.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To obtain information on safety aspects of the MSOT imaging device, side<br /><br>effects, adverse events (AE), serious adverse events (SAE) and suspected<br /><br>unexpected serious adverse reactions (SUSAR). </p><br>
© Copyright 2025. All Rights Reserved by MedPath